共 50 条
- [3] Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions FRONTIERS IN ONCOLOGY, 2023, 13
- [6] Mesotheliomas - current status in etiology, diagnostics, and molecular pathology PATHOLOGIE, 2024, 45 (05): : 303 - 304
- [10] Current status of molecular targeted therapy for hematologic malignancies: introduction International Journal of Clinical Oncology, 2014, 19 : 1 - 2